{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:11:17Z","timestamp":1794471077495,"version":"4.9.1"},"reference-count":30,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Peripheral T-cell lymphoma (PTCL) is a clinically aggressive disease, with a poor response to therapy and a low overall survival rate of approximately 30% after 5 years. We have analyzed a series of 105 cases with a diagnosis of PTCL using a customized NanoString platform (NanoString Technologies, Seattle, WA) that includes 208 genes associated with T-cell differentiation, oncogenes and tumor suppressor genes, deregulated pathways, and stromal cell subpopulations. A comparative analysis of the various histological types of PTCL (angioimmunoblastic T-cell lymphoma [AITL]; PTCL with T follicular helper [TFH] phenotype; PTCL not otherwise specified [NOS]) showed that specific sets of genes were associated with each of the diagnoses. These included TFH markers, cytotoxic markers, and genes whose expression was a surrogate for specific cellular subpopulations, including follicular dendritic cells, mast cells, and genes belonging to precise survival (NF-\u03baB) and other pathways. Furthermore, the mutational profile was analyzed using a custom panel that targeted 62 genes in 76 cases distributed in AITL, PTCL-TFH, and PTCL-NOS. The main differences among the 3 nodal PTCL classes involved the RHOAG17V mutations (P &amp;lt; .0001), which were approximately twice as frequent in AITL (34.09%) as in PTCL-TFH (16.66%) cases but were not detected in PTCL-NOS. A multivariate analysis identified gene sets that allowed the series of cases to be stratified into different risk groups. This study supports and validates the current division of PTCL into these 3 categories, identifies sets of markers that can be used for a more precise diagnosis, and recognizes the expression of B-cell genes as an IPI-independent prognostic factor for AITL.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005171","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T09:21:01Z","timestamp":1633080061000},"page":"5588-5598","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":57,"title":["Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers"],"prefix":"10.1182","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8543-6767","authenticated-orcid":false,"given":"Marta","family":"Rodr\u00edguez","sequence":"first","affiliation":[{"name":"Pathology Department, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), ISCIII, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9503-7268","authenticated-orcid":false,"given":"Ruth","family":"Alonso-Alonso","sequence":"additional","affiliation":[{"name":"Pathology Department, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), ISCIII, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tom\u00e1s-Roca","sequence":"additional","affiliation":[{"name":"Pathology Department, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2191-1327","authenticated-orcid":false,"given":"Socorro M.","family":"Rodr\u00edguez-Pinilla","sequence":"additional","affiliation":[{"name":"Pathology Department, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), ISCIII, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Manso-Alonso","sequence":"additional","affiliation":[{"name":"Pathology Department, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cereceda","sequence":"additional","affiliation":[{"name":"Pathology Department, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), ISCIII, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Borreg\u00f3n","sequence":"additional","affiliation":[{"name":"Pathology Department, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Villaescusa","sequence":"additional","affiliation":[{"name":"Lymphoma Unit, Department of Hematology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7654-8836","authenticated-orcid":false,"given":"Ra\u00fal","family":"C\u00f3rdoba","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), ISCIII, Madrid, Spain;"},{"name":"Lymphoma Unit, Department of Hematology, Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0058-7599","authenticated-orcid":false,"given":"Margarita","family":"S\u00e1nchez-Beato","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), ISCIII, Madrid, Spain;"},{"name":"Lymphoma Research Group, Medical Oncology Department, Instituto de Investigaci\u00f3n Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5136-7270","authenticated-orcid":false,"given":"Ismael","family":"Fern\u00e1ndez-Miranda","sequence":"additional","affiliation":[{"name":"Lymphoma Research Group, Medical Oncology Department, Instituto de Investigaci\u00f3n Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Betancor","sequence":"additional","affiliation":[{"name":"Pathology Department, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"B\u00e1rcena","sequence":"additional","affiliation":[{"name":"Pathology Department, Hospital Universitario 12 de Octubre, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), ISCIII, Madrid, Spain;"},{"name":"Pathology Department, Hospital MD Anderson Cancer Center, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Mollejo","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), ISCIII, Madrid, Spain;"},{"name":"Pathology Department, Hospital Virgen de la Salud, Toledo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Garc\u00eda-Cosio","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), ISCIII, Madrid, Spain;"},{"name":"Pathology Department, Hospital Universitario Ram\u00f3n y Cajal, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3274-4595","authenticated-orcid":false,"given":"Paloma","family":"Martin-Acosta","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), ISCIII, Madrid, Spain;"},{"name":"Pathology Department, Hospital Universitario Puerta de Hierro-Segovia de Arana, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fina","family":"Climent","sequence":"additional","affiliation":[{"name":"Pathology Department, Hospital Universitari de Bellvitge, IDIBELL, L\u2019Hospitalet de Llobregat, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Caballero","sequence":"additional","affiliation":[{"name":"Haematology Department, Hospitalario Universitario de Salamanca (HUS\/IBSAL), Salamanca, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"de la Fuente","sequence":"additional","affiliation":[{"name":"Bioinformatics Unit, Instituto de Investigaci\u00f3n Sanitaria-Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM), Madrid, Spain;"},{"name":"Department of Genetics, Instituto de Investigaci\u00f3n Sanitaria-Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM), Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4099-9421","authenticated-orcid":false,"given":"Pablo","family":"M\u00ednguez","sequence":"additional","affiliation":[{"name":"Bioinformatics Unit, Instituto de Investigaci\u00f3n Sanitaria-Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM), Madrid, Spain;"},{"name":"Department of Genetics, Instituto de Investigaci\u00f3n Sanitaria-Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM), Madrid, Spain;"},{"name":"Center for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8677-3252","authenticated-orcid":false,"given":"Linda","family":"Kessler","sequence":"additional","affiliation":[{"name":"Kura Oncology Inc., San Diego, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Scholz","sequence":"additional","affiliation":[{"name":"Kura Oncology Inc., San Diego, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gualberto","sequence":"additional","affiliation":[{"name":"Kura Oncology Inc., San Diego, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufino","family":"Mond\u00e9jar","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), ISCIII, Madrid, Spain;"},{"name":"UGC Laboratorios, Hospital Universitario de Puerto Real, C\u00e1diz, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5839-3634","authenticated-orcid":false,"given":"Miguel A.","family":"Piris","sequence":"additional","affiliation":[{"name":"Pathology Department, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), ISCIII, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"issue":"9","key":"2021122016304571500_B1","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) trials","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood."},{"issue":"22","key":"2021122016304571500_B2","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1200\/JCO.2006.09.4474","article-title":"Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas","volume":"25","author":"Cuadros","year":"2007","journal-title":"J Clin Oncol."},{"issue":"15","key":"2021122016304571500_B3","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","article-title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","volume":"133","author":"Heavican","year":"2019","journal-title":"Blood."},{"issue":"3","key":"2021122016304571500_B4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PAS.0000000000000555","article-title":"Angioimmunoblastic T-cell lymphomas with the RHOA p.Gly17val mutation have classic clinical and pathologic features","volume":"40","author":"Ondrejka","year":"2016","journal-title":"Am J Surg Pathol."},{"issue":"2","key":"2021122016304571500_B5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet."},{"issue":"18","key":"2021122016304571500_B6","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1200\/JCO.2016.71.2083","article-title":"Impact of expert pathologic review of lymphoma diagnosis: study of patients from the French lymphopath network","volume":"35","author":"Laurent","year":"2017","journal-title":"J Clin Oncol."},{"issue":"6","key":"2021122016304571500_B7","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3324\/haematol.2019.226647","article-title":"Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay","volume":"105","author":"Drieux","year":"2020","journal-title":"Haematologica."},{"issue":"6","key":"2021122016304571500_B8","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ajh.25450","article-title":"Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma","volume":"94","author":"Maura","year":"2019","journal-title":"Am J Hematol."},{"issue":"19","key":"2021122016304571500_B9","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood."},{"issue":"3","key":"2021122016304571500_B10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI26833","article-title":"Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets","volume":"117","author":"Piccaluga","year":"2007","journal-title":"J Clin Invest."},{"key":"2021122016304571500_B11","first-page":"861054","article-title":"Calling somatic SNVs and indels with mutect2","author":"Benjamin","journal-title":"bioRxiv"},{"issue":"4","key":"2021122016304571500_B12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0609.2007.00815.x","article-title":"Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience","volume":"78","author":"Rodr\u00edguez","year":"2007","journal-title":"Eur J Haematol."},{"issue":"4","key":"2021122016304571500_B13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.2900","article-title":"Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma","volume":"46","author":"Gunawardana","year":"2014","journal-title":"Nat Genet."},{"issue":"67","key":"2021122016304571500_B14","doi-asserted-by":"crossref","first-page":"111386","DOI":"10.18632\/oncotarget.22799","article-title":"Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets","volume":"8","author":"Mata","year":"2017","journal-title":"Oncotarget."},{"key":"2021122016304571500_B15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-319-99716-2_2","article-title":"Molecular and genomic landscape of peripheral T-cell lymphoma","volume":"176","author":"Iqbal","year":"2019","journal-title":"Cancer Treat Res."},{"issue":"11","key":"2021122016304571500_B16","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1080\/10428194.2016.1195500","article-title":"MUC1 in hematological malignancies","volume":"57","author":"Stroopinsky","year":"2016","journal-title":"Leuk Lymphoma."},{"issue":"6","key":"2021122016304571500_B17","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/bjh.15258","article-title":"Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T Cell Project Network","volume":"181","author":"Federico","year":"2018","journal-title":"Br J Haematol."},{"issue":"16","key":"2021122016304571500_B18","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol."},{"issue":"24","key":"2021122016304571500_B19","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood.2019000779","article-title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry","volume":"134","author":"Amador","year":"2019","journal-title":"Blood."},{"issue":"20","key":"2021122016304571500_B20","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood."},{"issue":"1","key":"2021122016304571500_B21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40164-021-00224-3","article-title":"Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas","volume":"10","author":"Yoon","year":"2021","journal-title":"Exp Hematol Oncol."},{"issue":"1","key":"2021122016304571500_B22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/bjh.16741","article-title":"Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study","volume":"192","author":"Rodriguez-Pinilla","year":"2021","journal-title":"Br J Haematol."},{"issue":"4","key":"2021122016304571500_B23","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2559.2011.04097.x","article-title":"Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres (pattern 1) shows superior survival to patterns 2 and 3: a meta-analysis of 56 cases","volume":"60","author":"Tan","year":"2012","journal-title":"Histopathology."},{"issue":"8","key":"2021122016304571500_B24","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.4049\/jimmunol.0901539","article-title":"TCR down-regulation controls T cell homeostasis","volume":"183","author":"Boding","year":"2009","journal-title":"J Immunol."},{"issue":"8","key":"2021122016304571500_B25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/intimm\/dxv022","article-title":"Fine-tuning of T-cell development by the CD3\u03b3 di-leucine-based TCR-sorting motif","volume":"27","author":"Lauritsen","year":"2015","journal-title":"Int Immunol."},{"issue":"11","key":"2021122016304571500_B26","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas","volume":"128","author":"Vallois","year":"2016","journal-title":"Blood."},{"issue":"22","key":"2021122016304571500_B27","doi-asserted-by":"crossref","first-page":"16124","DOI":"10.18632\/oncotarget.24592","article-title":"Overlap at the molecular and immunohistochemical levels between angioimmunoblastic T-cell lymphoma and a subgroup of peripheral T-cell lymphomas without specific morphological features","volume":"9","author":"Manso","year":"2018","journal-title":"Oncotarget."},{"issue":"1","key":"2021122016304571500_B28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40164-021-00200-x","article-title":"Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas","volume":"10","author":"Ye","year":"2021","journal-title":"Exp Hematol Oncol."},{"issue":"6","key":"2021122016304571500_B29","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/PAI.0000000000000644","article-title":"A survey of somatic mutations in 41 genes in a cohort of T-cell lymphomas identifies frequent mutations in genes involved in epigenetic modification","volume":"27","author":"Fernandez-Pol","year":"2019","journal-title":"Appl Immunohistochem Mol Morphol."},{"issue":"18","key":"2021122016304571500_B30","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1182\/blood-2014-02-555946","article-title":"The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature","volume":"123","author":"Manso","year":"2014","journal-title":"Blood."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/24\/5588\/1853862\/advancesadv2021005171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/24\/5588\/1853862\/advancesadv2021005171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T16:34:49Z","timestamp":1640018089000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/24\/5588\/477109\/Peripheral-T-cell-lymphoma-molecular-profiling"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,20]]},"references-count":30,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2021,12,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005171","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,20]]}}}